Visit SciVerse ScienceDirect to see if you have access via your institution.
More periodicals:
Bacterial Vaginosis: Balancing the Approach to Treatment
A supplement to Ob. Gyn. News.
Sponsored by Medical Educations Resources (MER) Inc.
Supported by an unrestricted educational grant from 3M Pharmaceuticals.
To view the supplement, click the image above. To take the CME test, download and print out the PDF file, and follow the test instructions on page 12.
Contents
New CDC Treatment Guidelines for STDs: An Overview David E. Soper, MD Professor, Department of Ob.Gyn.
Medical University of South Carolina
Charleston, SC
Financial Support: 3M Pharmaceuticals. Speakers' Bureaus: 3M Pharmaceuticals and Pfizer.
The Vaginal Ecosystem: Current Views Sharon L. Hillier, PhD Clinical Director
Obstetrics, Gynecology and Reproductive Sciences
University of Pittsburgh School of Medicine
Director, Reproductive Infectious Disease Research
Magee-Women's Hospital
Pittsburgh, PA
Clinical Grants: 3M Pharmaceuticals, Pfizer, Inc., and The Medicines Company; Consultant: 3M Pharmaceuticals, Johnson & Johnson Company, Cooper Surgical. Discusses the unlabeled use of Lactobacillus crispatus CTV OS vaginal capsules for recolonization of the vagina.
Recurrent Bacterial Vaginosis Jack D. Sobel, MD Professor, Chief
Division of Infectious Disease
Wayne State University School of Medicine
Harper Hospital
Detroit, MI
Clinical Grants: 3M Pharmaceuticals. Discusses the unlabeled use of metronidazole vaginal gel, 0.75%, in recurrent bacterial vaginosis.
Statement of Need
Bacterial vaginosis (BV) is a vaginal infection that causes discomfort and diminished quality of life for women as a result of vaginal discharge and an unpleasant amine odor. Often, BV is chronic. Beyond this, accumulating evidence indicates that BV also may be associated with other important health consequences, including an increased risk for pelvic inflammatory disease, preterm birth, and infections following gynecologic procedures. This educational activity provides clinicians with up-to-date information on BV, specifically regarding new findings in pathogenesis and etiology, natural history, clinical sequelae, and treatment of acute, recurring, and chronic infections.
Learning Objectives
After reading and studying the presentations and discussions in this supplement, participants should be prepared to:
• List the criteria for the diagnosis of bacterial vaginosis.
• Explain what is currently known about the normal vaginal ecosystem as well as the altered ecosystem associated with bacterial vaginosis.
• Describe what is currently understood about the pathogenesis and natural history of bacterial vaginosis.
• Discuss the objectives of treatment as well as the treatment options currently available for women with acute, recurring, and chronic bacterial vaginosis.
Accreditation
Medical Education Resources, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
Medical Education Resources designated this continuing medical education activity for 1 credit hour in Category 1 of the Physician's Recognition Award of the American Medical Association.
The CME activity was planned and produced in accordance with the ACCME Essentials.
